EVRA transdermal contraceptive patch

norelgestromin and ethinyl estradiol · Janssen Pharmaceuticals N.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EVRA transdermal contraceptive patch, covering 2010-11-16 to 2010-11-16. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception. [Phase 4]

See pricing